AEA Salicylic Acid Market by Application (Pharmaceutical, Skin Care, Haircare, and Food Preservatives & Others): Opportunity Analysis and Industry Forecast, 2021–2030

AEA Salicylic Acid Market by Application (Pharmaceutical, Skin Care, Haircare, and Food Preservatives & Others): Opportunity Analysis and Industry Forecast, 2021–2030

The AEA salicylic acid market was valued at $274.5 million in 2020, and is projected to reach $553.8 million by 2030, growing at a CAGR of 7.3% from 2020 to 2030.

Salicylic acid is a lipophilic monohydroxybenzoic acid, a type of phenolic acid, and a beta hydroxy acid, with the molecular formula C₇H₆O₃. In terms of physical properties, it is an odorless and colorless crystalline organic acid. Salicylic acid acts as an intermediate in the pharmaceutical and personal care industries. The AEA salicylic acid market estimation includes revenue reported by salicylic acid and its applications.

Owing to the anti-inflammatory properties of salicylic acid, it is highly preferred by pharmaceutical and skin care industries. Thus, the AEA salicylic acid market is anticipated to witness strong growth opportunities during the forecast period, owing to increase in demand from various end-use industries, including pharmaceutical, food & beverage, and cosmetic & personal care industries. Furthermore, salicylic acid is key ingredient in the manufacturing of aspirin. Aspirin is one of the most often prescribed pharmaceutical medications in the world, and its use is on rise due to its superior pain-relieving properties and ease of availability. In addition, it is increasingly being used to prevent and cure diseases such as dementia and strokes, particularly among the elderly, which is driving the demand for this medicine.

Moreover, salicylic acid is used in the personal care & cosmetics industry due to its oxidation property. Increase in number of individuals suffering from pimples, whiteheads, blackheads, warts, and zits is expected to further drive the demand for salicylic acid-based cosmetics. In addition, developments in personal care products are expected to support the growth of salicylic acid market during the forecast period.

Key benefits for stakeholders

The report provides an extensive qualitative and quantitative analysis of the current trends and future estimations of the market from 2021 to 2030 to determine the prevailing opportunities.
The study provides a comprehensive analysis of the factors that drive and restrict the growth of the market.
Porter’s five forces analysis helps analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.
Profiles of leading players operating in the market are provided to understand the competitive scenario.
The report provides extensive qualitative insights on the significant segments and regions exhibiting favorable growth.

Key market segments


By Application

Pharmaceuticals
Skin care
Haircare
Food preservatives & others

By Region

North America
U.S.
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Rest of Latin America
Europe
France
Germany
Italy
Spain
United Kingdom
Rest of Europe
Africa
Algeria
Egypt
Morocco
Rest of Africa

Key market players

Alfa Aesar
Avonchem limited
J.M. Loveridge limited
Novacyl
Midas Pharma GmbH
Wego Chemical Group
Solvay
Merck KGaA
Reagents

Other players in the market are Thermo Fisher Scientific, Alta Laboratories, and others.


List of Company Profiles

ALFA AESAR
AVONCHEM LIMITED
J.M. LOVERIDGE LTD.
NOVACYL
MIDAS PHARMA GmbH
WEGO CHEMICAL GROUP
LARACHEM INC
MERCK KGAA
REAGENTS
SOLVAY

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.5.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1.Surge in demand from preserved food & beverage industry
3.4.1.2.Increase in demand for personal care products
3.4.2.Restraint
3.4.2.1.Consumer awareness about harmful effects
3.4.3.Opportunities
3.4.3.1.High adoption of salicylic acid in pharmaceuticals and cosmetics
3.4.3.2.Rise in demand for aspirin drug
3.5.Value chain analysis
3.6.Patent analysis
3.6.1.Patent analysis by country
3.7.Value chain players
3.8.Pricing analysis
3.9.Salicylic acid derivative outlook (salicylates)
3.9.1.U.S.
3.9.2.Canada
3.9.3.Germany
3.9.4.UK
3.10.Salicylic acid derivatives
3.11.Impact of COVID-19 outbreak on the salicylic acid market
CHAPTER 4:AEA SALICYLIC ACID MARKET, BY APPLICATION
4.1.Overview
4.1.1.Market size and forecast, by region
4.2.Pharmaceutical
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Skin care
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Haircare
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Food preservative & others
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
CHAPTER 5:AEA SALICYLIC ACID MARKET, BY REGION
5.1.Overview
5.1.1.Market size and forecast, by region
5.2.North America
5.2.1.Key market trends, growth factors, and opportunity
5.2.2.Market Size and Forecast
5.2.3.Market size and forecast, by country
5.2.3.1.U.S.
5.2.3.1.1.Market size and forecast, by application
5.2.3.2.Canada
5.2.3.2.1.Market size and forecast, by application
5.2.3.3.Mexico
5.2.3.3.1.Market size and forecast, by application
5.3.Latin America
5.3.1.Key market trends, growth factors, and opportunity
5.3.2.Market Size and Forecast
5.3.3.Market size and forecast, by country
5.3.3.1.Brazil
5.3.3.1.1.Market size and forecast, by application
5.3.3.2.Argentina
5.3.3.2.1.Market size and forecast, by application
5.3.3.3.Chile
5.3.3.3.1.Market size and forecast, by application
5.3.3.4.Rest of Latin America
5.3.3.4.1.Market size and forecast, by application
5.4.Europe
5.4.1.Key market trends, growth factors, and opportunity
5.4.2.Market Size and Forecast
5.4.3.Market size and forecast, by country
5.4.3.1.France
5.4.3.1.1.Market size and forecast, by application
5.4.3.2.Germany
5.4.3.2.1.Market size and forecast, by application
5.4.3.3.Italy
5.4.3.3.1.Market size and forecast, by application
5.4.3.4.Spain
5.4.3.4.1.Market size and forecast, by application
5.4.3.5.UK
5.4.3.5.1.Market size and forecast, by application
5.4.3.6.Rest of Europe
5.4.3.6.1.Market size and forecast, by application
5.5.Africa
5.5.1.Key market trends, growth factors, and opportunity
5.5.2.Market Size and Forecast
5.5.3.Market size and forecast, by country
5.5.3.1.Algeria
5.5.3.1.1.Market size and forecast, by application
5.5.3.2.Egypt
5.5.3.2.1.Market size and forecast, by application
5.5.3.3.Morocco
5.5.3.3.1.Market size and forecast, by application
5.5.3.4.Rest of Africa
5.5.3.4.1.Market size and forecast, by application
CHAPTER 6:COMPETITIVE LANDSCAPE
6.1.Introduction
6.1.1.Market player positioning
6.2.Competitive heatmap
6.3.Key developments
6.3.1.Business expansion
6.3.2.Expansions
CHAPTER 7:COMPANY PROFILES
7.1.ALFA AESAR
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.2.AVONCHEM LIMITED
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.3.J.M. LOVERIDGE LTD.
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segment
7.3.4.Product portfolio
7.4.NOVACYL
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Key strategic moves and developments
7.5.MIDAS PHARMA GmbH
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.6.WEGO CHEMICAL GROUP
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Product portfolio
7.7.LARACHEM INC.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Product portfolio
7.8.MERCK KGAA
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Research and development
7.8.6.Business performance
7.9.REAGENTS
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Product portfolio
7.10.SOLVAY
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Research and development
7.10.6.Business performance
LIST OF TABLES
TABLE 01.LIST OFVALUE CHAIN PLAYERS
TABLE 02.LIST OF SALICYLIC ACID DERIVATIVES
TABLE 03.AEA SALICYLIC ACID MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 04.AEA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 05.AEA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 06.AEA SALICYLIC ACID MARKET FOR PHARMACEUTICAL, BY REGION, 2020–2030 (TON)
TABLE 07.AEA SALICYLIC ACID MARKET FOR PHARMACEUTICAL, BY REGION,2020–2030 ($MILLION)
TABLE 08.AEA SALICYLIC ACID MARKET FOR SKIN CARE, BY REGION,2020–2030 (TON)
TABLE 09.AEA SALICYLIC ACID MARKET FOR SKIN CARE, BY REGION,2020–2030 ($MILLION)
TABLE 10.AEA SALICYLIC ACID MARKET FOR HAIRCARE, BY REGION,2020–2030 (TON)
TABLE 11.AEA SALICYLIC ACID MARKET FOR HAIRCARE, BY REGION,2020–2030 ($MILLION)
TABLE 12.SALICYLIC ACID MARKET FOR FOOD PRESERVATIVE & OTHERS, BY REGION, 2020–2030 (TON)
TABLE 13.SALICYLIC ACID MARKET FOR FOOD PRESERVATIVE & OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 14.AEA SALICYLIC ACID MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
TABLE 15.AEA SALICYLIC ACID MARKET, BY REGION, 2020–2030 (TON)
TABLE 16.AEA SALICYLIC ACID MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 18.NORTH AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 19.NORTH AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 20.NORTH AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 21.U.S. SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 22.U.S. SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 23.CANADA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 24.CANADA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 25.MEXICO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 26.MEXICO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 27.LATIN AMERICASALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 28.LATIN AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 29.LATIN AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 30.LATIN AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 31.BRAZIL SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 32.BRAZIL SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 33.ARGENTINA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 34.ARGENTINA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35.CHILE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 36.CHILE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 37.REST OF LATIN AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 38.REST OF LATIN AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 39.EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 40.EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 41.EUROPE SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 42.EUROPE SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 43.FRANCE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 44.FRANCE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 45.GERMANY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 46.GERMANY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 47.ITALY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 48.ITALY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 49.SPAIN SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 50.SPAIN SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 51.UK SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 52.UK SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 53.REST OF EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 54.REST OF EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 55.AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 56.AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 57.AFRICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 58.AFRICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 59.ALGERIA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 60.ALGERIA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 61.EGYPT SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 62.EGYPT SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 63.MOROCCO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 64.MOROCCO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 65.REST OF AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 66.REST OF AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 67.KEY EXPANSIONS
TABLE 68.ALFA: COMPANY SNAPSHOT
TABLE 69.ALFA: OPERATING SEGMENTS
TABLE 70.ALFA: PRODUCT PORTFOLIO
TABLE 71.AVONCHEM: COMPANY SNAPSHOT
TABLE 72.AVONCHEM: OPERATING SEGMENTS
TABLE 73.AVONCHEM: PRODUCT PORTFOLIO
TABLE 74.J.M. LOVERIDGE: COMPANY SNAPSHOT
TABLE 75.J.M. LOVERIDGE: OPERATING SEGMENT
TABLE 76.J.M. LOVERDIGE: PRODUCT PORTFOLIO
TABLE 77.NOVACYL: COMPANY SNAPSHOT
TABLE 78.NOVACYL: OPERATING SEGMENTS
TABLE 79.NOVACYL: PRODUCT PORTFOLIO
TABLE 80.NOVACYL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 81.MIDAS PHARMA: COMPANY SNAPSHOT
TABLE 82.MIDAS PHARMA: OPERATING SEGMENTS
TABLE 83.MIDAS PHARMA: PRODUCT PORTFOLIO
TABLE 84.WEGO: COMPANY SNAPSHOT
TABLE 85.WEGO: PRODUCT PORTFOLIO
TABLE 86.LARACHEM INC.: COMPANY SNAPSHOT
TABLE 87.LARACHEM INC.: PRODUCT PORTFOLIO
TABLE 88.MERCK: COMPANY SNAPSHOT
TABLE 89.MERCK: OPERATING SEGMENTS
TABLE 90.MERCK: PRODUCT PORTFOLIO
TABLE 91.MERCK: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 92.MERCK: NET SALES, 2018–2020 ($MILLION)
TABLE 93.REAGENTS: COMPANY SNAPSHOT
TABLE 94.REAGENTS: PRODUCT PORTFOLIO
TABLE 95.SOLVAY: COMPANY SNAPSHOT
TABLE 96.SOLVAY: OPERATING SEGMENTS
TABLE 97.SOLVAY: PRODUCT PORTFOLIO
TABLE 98.SOLVAY: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 99.SOLVAY: NET SALES, 2018–2020 ($MILLION)
LIST OF FIGURES
FIGURE 01.AEA SALICYLIC ACID MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS, BY COUNTRY
FIGURE 03.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 04.HIGH BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE THREAT OF NEW ENTRANTS
FIGURE 06.MODERATE THREAT OF SUBSTITUTES
FIGURE 07.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 08.AEA SALICYLIC ACID MARKET DYNAMICS
FIGURE 09.PATENT ANALYSIS, BY COUNTRY
FIGURE 10.PATENT ANALYSIS, BY APPLICANT
FIGURE 11.PATENT ANALYSIS, BY INVENTOR
FIGURE 12.SALICYLIC ACID PRICING ANALYSIS, BY REGION, (2020-2030)
FIGURE 13.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 14.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 15.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 16.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 17.COMPARATIVE ANALYSIS OF AEA SALICYLIC ACID MARKET FOR PHARMACEEUTICAL, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF AEA SALICYLIC ACID MARKET FOR SKIN CARE, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF AEA SALICYLIC ACID MARKET FOR HAIRCARE, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF SALICYLIC ACID MARKET FOR FOOD PRESERVATIVE & OTHERS, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 21.U.S. SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 22.CANADA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 23.MEXICO SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 24.BRAZIL SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 25.ARGENTINA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 26.CHILE SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 27.REST OF LATIN AMERICA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 28.FRANCE SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 29.GERMANY SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 30.ITALY SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 31.SPAIN SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 32.UK SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 33.REST OF EUROPE SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 34.ALGERIA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 35.EGYPT SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 36.MOROCCO SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 37.REST OF AFRICA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 38.MARKET PLAYER POSITIONING
FIGURE 39.COMPETITIVE HEATMAP OF KEY PLAYERS
FIGURE 40.MERCK: R&D, 2018–2020 ($MILLION)
FIGURE 41.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.MERCK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 44.SOLVAY: R&D, 2018–2020 ($MILLION)
FIGURE 45.SOLVAY: NET SALES, 2018–2020 ($MILLION)
FIGURE 46.SOLVAY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47.SOLVAY: REVENUE SHARE BY REGION, 2020 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings